Anxiety Clinical Trials in Ohio

18 recruiting studies across 2 cities

Browse by City

All Trials in Ohio

Phase

Trial	Phase	Sponsor	Dist.
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder	Phase 2	AbbVie	<1 mi
Weighted Blanket Use to Reduce Anxiety in Oncology Patients	N/A	Ohio State University Comprehensive Cancer Center	<1 mi
Pre-Operative Guided Meditation to Reduce Pre-Operative Anxiety in Patients Undergoing Cancer-Directed Surgery	N/A	Ohio State University Comprehensive Cancer Center	<1 mi
Anxiety Sensitivity Treatment to Reduce Anxiety in Alzheimer's	N/A	Florida State University	<1 mi
Uncertainty and Firearms: Obtaining Secure Storage	N/A	Ohio State University	<1 mi
The Mom and Infant Outcomes (MOMI) Study	N/A	Ohio State University	<1 mi
Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder	Phase 2	Intra-Cellular Therapies, Inc.	<1 mi
The Impact of Focused Ultrasound Thalamotomy of the Anterior Nucleus for Focal-Onset Epilepsy on Anxiety	Phase 1	Ohio State University	<1 mi
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses	Phase 2	Reunion Neuroscience Inc	<1 mi
A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder	Phase 2	VistaGen Therapeutics, Inc.	<1 mi
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Voyage)	Phase 3	Definium Therapeutics US, Inc.	<1 mi
Effects of Lavender Aromatherapy on Patient Anxiety During Mohs Micrographic Surgery	N/A	Case Comprehensive Cancer Center	<1 mi
Developing Resilience and Anxiety Management Through the Arts	N/A	Case Western Reserve University	<1 mi
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)	Phase 2	Seaport Therapeutics	10 mi
P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety	Phase 3	Otsuka Pharmaceutical Development & Commercialization, Inc.	10 mi
Technology Assisted Treatment of Trichotillomania: Open Trial	N/A	HabitAware Inc.	30 mi
Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder	Phase 2	Intra-Cellular Therapies, Inc.	46 mi
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)	Phase 3	Definium Therapeutics US, Inc.	46 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.